NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-241-2006-0-PCT-01 Method For Determining Risk of Elderly Patient Under Medical Treatment and Related Systems PCT PCT PCT/US2006/44718 Abandoned
NCI E-119-2006-0-PCT-02 Trioxane Dimers Having Surprisingly High Anticancer Activities Adn Surprisingly Long-lasting Antimalarial Activities PCT PCT PCT/US06/044845 Expired
NIDCR E-038-2013-0-US-01 SYNTHETIC TRITERPENOIDS AND TRICYCLIC-BIS-ENONES FOR USE IN STIMULATING BONE AND CARTILAGE GROWTH US 61/866,344 Abandoned
NCI E-230-2006-0-PCT-02 Pharmaceutical Composition And Method For Regulating Abnormal Cellular Proliferation PCT PCT PCT/IL2006/001324 Expired
NCI E-230-2006-0-EP-03 Pharmaceutical Composition And Method For Regulating Abnormal Cellular Proliferation EP National Stage 06809878.9 Abandoned
NCI E-230-2006-0-IL-04 Pharmaceutical Composition And Method For Regulating Abnormal Cellular Proliferation IL National Stage 191416 Abandoned
NCI E-297-2006-0-US-01 CCR5-Specific Human Monoclonal Antibodies US 60/859,401 Abandoned
NHLBI E-249-2006-0-US-01 A Device To Protect Coronary Arteries Against Compression During Transcatheter Mitral Valve Annuloplasty (PMVA) US 60/858,716 Abandoned
NCI E-058-2006-0-US-02 Tymidylate Kinase Mutants and Uses Therof US ORD 11/559,757 Abandoned
NCI E-058-2006-0-CA-03 Tymidylate Kinase Mutants and Uses Therof CA ORD 2566267 Abandoned
NCI E-029-2006-1-FR-17 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF FR EP 06837414.9 Issued
NCI E-029-2006-1-DE-16 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF DE EP 06837414.9 Issued
NCI E-029-2006-1-IT-20 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF IT EP 06837414.9 Issued
NCI E-029-2006-1-IE-19 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF IE EP 06837414.9 Abandoned
NCI E-029-2006-1-GB-18 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF GB EP 06837414.9 Issued
NCI E-029-2006-1-CH-15 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF CH EP 06837414.9 Abandoned
NCI E-106-2003-0-IL-08 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use IL National Stage 179236 Issued
NCI E-029-2006-1-CA-03 N-Substituted Indenoisoquinolines And Syntheses Thereof CA National Stage 2629530 Abandoned
NCI E-029-2006-1-JP-05 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment JP National Stage 2008-541244 Issued
NCI E-029-2006-1-AU-02 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment AU National Stage 2006315599 Abandoned
NIAID E-218-2004-0-US-03 Human Immunodeficiency Virus (HIV) Immunization Strategies Employing Conformationally-Stabilized, Surface-Occluded Peptides Comprising A GP41 2F5 Epitope in Association with Lipid US National Stage 11/596,494 8147840 Issued PDF
NIEHS E-130-2004-0-US-06 Methods Related to the Treatment of Neurodegenerative and Inflammatory Conditions US National Stage 11/596,296 8088787 Issued PDF
NHLBI E-003-2000-0-US-04 Regulators of Type-1 Tumor Necrosis Factor Receptor and Other Cytokine Receptor Shedding US DIV 11/598,473 Abandoned
NCI E-029-2006-1-PCT-01 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment PCT PCT COMB PCT/US2006/043933 Expired
NIA E-016-2004-0-JP-05 Method of Inhibiting Profinflammatory Cytokine Expression Using Ghrelin JP National Stage 2007-513335 Abandoned
NCI E-019-2006-0-PCT-02 MATERIALS AND METHODS FOR ABCB1 POLYMORPHIC VARIANT SCREENING, DIAGNOSIS, AND TREATMENT PCT PCT PCT/US2006/043656 Abandoned
NCI E-019-2006-0-JP-06 MATERIALS AND METHODS FOR ABCB1 POLYMORPHIC VARIANT SCREENING, DIAGNOSIS, AND TREATMENT JP National Stage 2008-540194 Abandoned
NIAID E-151-1992-0-JP-12 INTERLEUKIN-4 STIMULATED T LYMPHOCYTE CELL DEATH JP DIV 2006-303894 Abandoned
NCI E-019-2006-0-EP-05 MATERIALS AND METHODS FOR ABCB1 POLYMORPHIC VARIANT SCREENING, DIAGNOSIS, AND TREATMENT EP National Stage 06837251.5 Abandoned
NCI E-019-2006-0-AU-03 MATERIALS AND METHODS FOR ABCB1 POLYMORPHIC VARIANT SCREENING, DIAGNOSIS, AND TREATMENT AU National Stage 2006315760 Abandoned
NIAID E-029-2007-0-US-01 Absence or Over-expression of the Varicella-Zoster Virus (VZV) ORF29 Latency Associated Protein Impairs Late Gene Expressions and Reduces VZV Latency in Rodents4 US 60/857,766 Abandoned
NCI E-285-2006-0-US-01 DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS US 60/858,068 Abandoned
NCI E-019-2006-0-CA-04 MATERIALS AND METHODS FOR ABCB1 POLYMORPHIC VARIANT SCREENING, DIAGNOSIS, AND TREATMENT CA National Stage 2629155 Abandoned
NCI E-119-2007-0-US-03 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY US ORD 11/557,835 7611702 Issued PDF
NCI E-261-2005-2-PCT-01 Method For Diagnosing And Monitoring The Progression Of Cancer PCT PCT COMB PCT/US2006/043654 Expired
NCI E-118-2007-0-US-03 Prevention And Treatment Of Enterocolitis Associated With The Administration Of Anti-CTLA-4 Antibody [Using Non-absorbable Steriod] US ORD 11/557,844 Abandoned
NCI E-119-2007-0-CN-04 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY CN National Stage 200680040513.9 Pending
NCI E-119-2007-0-JP-05 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY JP National Stage 2008-540197 Pending
NCI E-119-2007-0-EP-09 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY EP National Stage 06827682.3 Abandoned
NCI E-119-2007-0-MX-06 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY MX National Stage MX/A/2008/005674 Abandoned
NCI E-119-2007-0-AU-07 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY AU National Stage 2006311475 Abandoned
NCI E-119-2007-0-IL-10 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY IL National Stage 1983-01-19 Abandoned
NCI E-119-2007-0-CA-08 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY CA National Stage 2626859 Abandoned
NCI E-119-2007-0-PCT-02 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY PCT PCT PCT/US06/043691 Abandoned
NCI E-118-2007-0-PCT-02 Prevention And Treatment Of Enterocolitis Associated With The Administration Of Anti-CTLA-4 Antibody [Using Non-absorbable Steriod] PCT PCT PCT/US06/043690 Abandoned
NIDCR E-018-2003-0-US-02 Postnatal Stem Cells And Uses Thereof US National Stage 10/553,633 9175264 Issued PDF
NIAID E-090-1996-0-US-08 CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION US DIV 11/594,375 7374872 Abandoned PDF
NCI E-256-2006-0-US-01 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs US 60/864,665 Abandoned
NIDDK E-022-2007-0-US-01 IDENTIFICATION OF AN IRON REGULATION MECHANISM IN PATIENTS WITH BETA-THALASSEMIA US 60/864,705 Abandoned
NCI E-208-2006-0-US-01 Detection And Subtyping Of Influenza Strains (including All Known Human And Avian Strains) With Genome-tiling Oligonucleotide Microarray US 60/857,695 Abandoned